Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 260

1.

An emerging complexity of receptors for transforming growth factor-beta.

Derynck R, Chen RH, Ebner R, Filvaroff EH, Lawler S.

Princess Takamatsu Symp. 1994;24:264-75. Review.

PMID:
8983081
2.

Functional roles for the cytoplasmic domain of the type III transforming growth factor beta receptor in regulating transforming growth factor beta signaling.

Blobe GC, Schiemann WP, Pepin MC, Beauchemin M, Moustakas A, Lodish HF, O'Connor-McCourt MD.

J Biol Chem. 2001 Jul 6;276(27):24627-37. Epub 2001 Apr 25.

3.
4.

Betaglycan inhibits TGF-beta signaling by preventing type I-type II receptor complex formation. Glycosaminoglycan modifications alter betaglycan function.

Eickelberg O, Centrella M, Reiss M, Kashgarian M, Wells RG.

J Biol Chem. 2002 Jan 4;277(1):823-9. Epub 2001 Oct 19.

5.

TGF-beta receptors: structure and function.

Lin HY, Moustakas A.

Cell Mol Biol (Noisy-le-grand). 1994 May;40(3):337-49. Review.

PMID:
7920178
6.
7.

Signaling activity of homologous and heterologous transforming growth factor-beta receptor kinase complexes.

Vivien D, Attisano L, Wrana JL, Massagué J.

J Biol Chem. 1995 Mar 31;270(13):7134-41.

8.

TGF-(beta) type I receptor/ALK-5 and Smad proteins mediate epithelial to mesenchymal transdifferentiation in NMuMG breast epithelial cells.

Piek E, Moustakas A, Kurisaki A, Heldin CH, ten Dijke P.

J Cell Sci. 1999 Dec;112 ( Pt 24):4557-68.

10.

Transforming growth factor (TGF-beta)-specific signaling by chimeric TGF-beta type II receptor with intracellular domain of activin type IIB receptor.

Persson U, Souchelnytskyi S, Franzén P, Miyazono K, ten Dijke P, Heldin CH.

J Biol Chem. 1997 Aug 22;272(34):21187-94.

11.

Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.

Schniewind B, Groth S, Sebens Müerköster S, Sipos B, Schäfer H, Kalthoff H, Fändrich F, Ungefroren H.

Oncogene. 2007 Jul 19;26(33):4850-62. Epub 2007 Feb 12.

PMID:
17297450
12.

Transforming growth factor-beta signalling in extraembryonic mesoderm is required for yolk sac vasculogenesis in mice.

Goumans MJ, Zwijsen A, van Rooijen MA, Huylebroeck D, Roelen BA, Mummery CL.

Development. 1999 Aug;126(16):3473-83.

13.

Lack of responsiveness to TGF-beta1 in a thyroid carcinoma cell line with functional type I and type II TGF-beta receptors and Smad proteins, suggests a novel mechanism for TGF-beta insensitivity in carcinoma cells.

Heldin NE, Bergström D, Hermansson A, Bergenstråhle A, Nakao A, Westermark B, ten Dijke P.

Mol Cell Endocrinol. 1999 Jul 20;153(1-2):79-90.

PMID:
10459856
14.

Supplemental Content

Support Center